These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36809348)

  • 1. Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial.
    Michaud TL; Wilson KE; Katula JA; You W; Estabrooks PA
    Transl Behav Med; 2023 Jul; 13(7):501-510. PubMed ID: 36809348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and Cost-Effectiveness of Implementing a Digital Diabetes Prevention Program in a Large, Integrated Health System.
    Smith DH; O'Keeffe-Rosetti M; Fitzpatrick SL; Mayhew M; Firemark AJ; Gruß I; Nyongesa DB; Smith N; Dickerson JF; Stevens VJ; Vollmer WM; Fortmann SP
    Perm J; 2022 Sep; 26(3):74-82. PubMed ID: 36038966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
    Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
    BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial.
    Singh K; Kondal D; Menon VU; Varthakavi PK; Viswanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Phillips VL; Tandon N; Ali MK
    Diabet Med; 2023 Sep; 40(9):e15074. PubMed ID: 36815284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of a group translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes.
    Lawlor MS; Blackwell CS; Isom SP; Katula JA; Vitolins MZ; Morgan TM; Goff DC
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S381-9. PubMed ID: 23498303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
    Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program.
    Hollenbeak CS; Weinstock RS; Cibula D; Delahanty LM; Trief PM
    Health Serv Insights; 2016; 9():21-8. PubMed ID: 27429556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of metformin in the US diabetes prevention program trial: Simple interpretations need not apply.
    Rittenhouse BE; Alolayan S; Eguale T; Segal AR; Doucette J
    Prev Med; 2024 Jan; 178():107819. PubMed ID: 38092328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
    Islek D; Weber MB; Ranjit Mohan A; Mohan V; Staimez LR; Harish R; Narayan KMV; Laxy M; Ali MK
    JAMA Netw Open; 2020 Jul; 3(7):e207539. PubMed ID: 32725244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
    Hernan WH; Brandle M; Zhang P; Williamson DF; Matulik MJ; Ratner RE; Lachin JM; Engelgau MM;
    Diabetes Care; 2003 Jan; 26(1):36-47. PubMed ID: 12502656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
    Png ME; Yoong JS
    PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.